Yangyang Cheng
Key Laboratory Of Carcinogenesis And Translational Research
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
A Novel Dual-Gradient Patterned Wettability Current Collector for Passive DMFCs.
Journal: Nanomaterials (Basel, Switzerland)
Published: March 19, 2026
Berberine: A Negentropic Modulator for Multi-System Coordination.
Journal: International journal of molecular sciences
Published: December 09, 2025
Enhancing the Therapeutic Efficacy of Berberine and Quercetin Through Salt Formulation for Liver Fibrosis Treatment.
Journal: International journal of molecular sciences
Published: December 23, 2024
Corrigendum: Induction of RIPK3/MLKL-mediated necroptosis by Erigeron breviscapus injection exhibits potent antitumor effect.
Journal: Frontiers in pharmacology
Published: August 03, 2023
Ceruloplasmin is associated with the infiltration of immune cells and acts as a prognostic biomarker in patients suffering from glioma.
Journal: Frontiers in pharmacology
Published: June 29, 2023
Induction of RIPK3/MLKL-mediated necroptosis by Erigeron breviscapus injection exhibits potent antitumor effect.
Journal: Frontiers in pharmacology
Published: May 09, 2023
Experiment and Modelling of the Pre-Strain Effect on the Creep Behaviour of P/M Ni-Based Superalloy FGH96.
Journal: Materials (Basel, Switzerland)
Published: April 12, 2023
Palmatine Derivatives as Potential Antiplatelet Aggregation Agents via Protein Kinase G/Vasodilator-Stimulated Phosphoprotein and Phosphatidylinositol 3-Kinase/Akt Phosphorylation.
Journal: Journal of medicinal chemistry
Published: May 13, 2022
Epidemiological Characteristics of Peripheral T-Cell Lymphoma: A Population-Based Study.
Journal: Frontiers in oncology
Published: January 27, 2022
Evaluation of Different Breast Cancer Screening Strategies for High-Risk Women in Beijing, China: A Real-World Population-Based Study.
Journal: Frontiers in oncology
Published: September 14, 2021
Berberine and Its Main Metabolite Berberrubine Inhibit Platelet Activation Through Suppressing the Class I PI3Kβ/Rasa3/Rap1 Pathway.
Journal: Frontiers in pharmacology
Published: July 01, 2021
A network analysis framework of genetic and nongenetic risks for type 2 diabetes.
Journal: Reviews in endocrine & metabolic disorders
Published: August 26, 2020
Last Updated: 09/26/2026